Clinical Trials Browser

Phase 2 × Prostate Adenocarcinoma × radium Ra 223 dichloride × Clear all

NCT03361735 2025-05-02

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Phase 2 Active not recruiting

Prostate Adenocarcinoma